Filling the need for trusted information on health issues…

Trending on kff Enrollment Marketplaces Medicare Advantage

Treatment and Prevention Strategies

  • your selections
Clear Search

Filter Results

date

Tags

  • results
Public Health Advocates Seek Lower Prices For Hepatitis C Treatments

Nature: Hepatitis C drugs not reaching poor “…Three decades after wrestling to lower the cost of AIDS drugs (prices fell from about US$10,000 per patient per year in the 1990s to less than $100 in the mid-2000s), [public health researchers] are once again asking how expensive life-saving medicines can be…

Children Receive Less Effective Diarrhea Care In Private Sub-Saharan African Hospitals

“Children in sub-Saharan Africa who suffer from diarrhea are receiving lifesaving treatment at a lower rate when visiting private hospitals as compared to public ones. Closing that gap would save an estimated 20,000 lives each year,” development blogger Tom Murphy writes in a post on Humanosphere. Murphy examines the findings…

Clinical Trials Of Hepatitis C Treatments Show Success

News outlets examine recently released clinical trial results of hepatitis C treatments. Financial Times: Drug groups step up race for hepatitis C treatments “Drugmakers are stepping up the race for multibillion-dollar hepatitis C treatments after trial data showed how the disease had become one of the most promising areas of…

U.S.-Funded Research On Ebola Treatments Shows Progress

CQ HealthBeat: U.S.-Funded Ebola Drugs Make Gains in Testing “While global health agencies confront the recent Ebola outbreak in western Africa, researchers funded by federal agencies are gaining ground in efforts to develop medicines to combat the deadly virus…” (Young, 4/11).

Russia’s Takeover Of Crimea Negatively Impacting HIV Prevention Services

The Independent: Battling AIDS: Former health secretary claims Russia is causing setback in efforts to defeat the virus Norman Fowler, former British health secretary “…One of the unwelcome first results of the Russian takeover of Crimea has been a radical change in policy on the treatment of injecting drug users.…

Some Countries Win Lower Pricing For Hepatitis C Treatment; Pharma Defends High Cost

News outlets report on developments surrounding the pricing of Gilead’s hepatitis C treatment, Sovaldi. Bloomberg News: Developing Countries Pay 1% of U.S. Price for Gilead’s Sovaldi “Developing countries such as Egypt, India, and Brazil won discounts to pay one percent of the $84,000 price Gilead Sciences Inc. is charging U.S.…

Learning From HIV To Treat, Prevent HPV, Other Cancers

The Hill: HPV may be the new HIV Elizabeth Chabner Thompson, founder of BFFL Co. “In May, I will be traveling with a group of physicians to Botswana for a conference sponsored by the Ministry of Health and several other organizations in hopes to inspire discussion around cancer care in…

Working Together, Global Community Can Defeat Vector-Borne Diseases

Katherine Bliss, senior associate at the Global Health Policy Center of the Center for Strategic and International Studies (CSIS), writes in the center’s “Smart Global Health” blog about this year’s World Health Day, the theme of which was “preventing vector-borne diseases.” She writes, “With more than one billion people globally…

WHO Releases Hepatitis C Treatment Guidelines Amid Calls For Lower Cost Treatment

Media sources report on the WHO’s first-ever hepatitis C treatment guidelines and increased efforts to lower the cost of the most effective treatments. Financial Times: Price of hepatitis C drug attacked “Gilead Sciences is facing mounting pressure over its new $1,000-a-day hepatitis C drug after the World Health Organization joined…

Al Jazeera’s ‘Lifelines’ Series Posts New Content

Al Jazeera: Lifelines: The Quest for Global Health The news service posts new information in its “Lifelines” series, including pages focused on rabies, river blindness, trachoma, malaria, and schistosomiasis (4/10).